Frequencies for first 10,000 rows of indi_pt variable in indi2010q3 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL DISCOMFORT | 9 0.09 0.09 ABDOMINAL DISTENSION | 1 0.01 0.10 ABDOMINAL PAIN | 11 0.11 0.21 ABDOMINAL PAIN LOWER | 1 0.01 0.22 ABDOMINAL PAIN UPPER | 2 0.02 0.24 ABNORMAL BEHAVIOUR | 1 0.01 0.25 ABNORMAL FAECES | 1 0.01 0.26 ABNORMAL SLEEP-RELATED EVENT | 1 0.01 0.27 ABORTION SPONTANEOUS | 1 0.01 0.28 ABSCESS JAW | 2 0.02 0.30 ABSCESS LIMB | 1 0.01 0.31 ACCIDENTAL EXPOSURE | 4 0.04 0.35 ACNE | 11 0.11 0.46 ACNE CYSTIC | 2 0.02 0.48 ACQUIRED IMMUNODEFICIENCY SYNDROME | 10 0.10 0.58 ACROMEGALY | 3 0.03 0.61 ACUTE CORONARY SYNDROME | 2 0.02 0.63 ACUTE LEUKAEMIA | 1 0.01 0.64 ACUTE LYMPHOCYTIC LEUKAEMIA | 26 0.26 0.90 ACUTE MYELOID LEUKAEMIA | 8 0.08 0.98 ACUTE MYELOID LEUKAEMIA (IN REMISSION) | 1 0.01 0.99 ACUTE MYELOID LEUKAEMIA RECURRENT | 3 0.03 1.02 ACUTE MYOCARDIAL INFARCTION | 2 0.02 1.04 ADENOCARCINOMA PANCREAS | 3 0.03 1.07 ADENOVIRUS INFECTION | 1 0.01 1.08 ADJUVANT THERAPY | 2 0.02 1.10 ADRENAL INSUFFICIENCY | 4 0.04 1.14 ADULT T-CELL LYMPHOMA/LEUKAEMIA | 12 0.12 1.26 ADVERSE DRUG REACTION | 2 0.02 1.28 ADVERSE EVENT | 5 0.05 1.33 AFFECT LABILITY | 10 0.10 1.43 AFFECTIVE DISORDER | 5 0.05 1.48 AGGRESSION | 1 0.01 1.49 AGITATION | 10 0.10 1.59 ALANINE AMINOTRANSFERASE INCREASED | 1 0.01 1.60 ALCOHOL USE | 2 0.02 1.62 ALLERGIC COUGH | 1 0.01 1.63 ALLOGENIC BONE MARROW TRANSPLANTATION.. | 1 0.01 1.64 ALOPECIA | 1 0.01 1.65 AMENORRHOEA | 1 0.01 1.66 AMINO ACID LEVEL DECREASED | 1 0.01 1.67 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 1.68 ANAEMIA | 17 0.17 1.85 ANAEMIA HAEMOLYTIC AUTOIMMUNE | 1 0.01 1.86 ANAEMIA OF CHRONIC DISEASE | 1 0.01 1.87 ANAEMIA PROPHYLAXIS | 2 0.02 1.89 ANAESTHESIA | 12 0.12 2.01 ANALGESIC THERAPY | 14 0.14 2.15 ANDROGENETIC ALOPECIA | 1 0.01 2.16 ANGINA PECTORIS | 10 0.10 2.26 ANGIOEDEMA | 1 0.01 2.27 ANGIOGRAM | 5 0.05 2.32 ANKYLOSING SPONDYLITIS | 22 0.22 2.54 ANTACID THERAPY | 1 0.01 2.55 ANTIALLERGIC THERAPY | 1 0.01 2.56 ANTIBIOTIC PROPHYLAXIS | 15 0.15 2.71 ANTIBIOTIC THERAPY | 8 0.08 2.79 ANTICOAGULANT THERAPY | 6 0.06 2.85 ANTIDEPRESSANT THERAPY | 6 0.06 2.91 ANTIEMETIC SUPPORTIVE CARE | 4 0.04 2.95 ANTIFUNGAL PROPHYLAXIS | 11 0.11 3.06 ANTIINFLAMMATORY THERAPY | 3 0.03 3.09 ANTIPLATELET THERAPY | 5 0.05 3.14 ANTIRETROVIRAL THERAPY | 9 0.09 3.23 ANTIVIRAL PROPHYLAXIS | 6 0.06 3.29 ANTIVIRAL TREATMENT | 4 0.04 3.33 ANXIETY | 67 0.67 4.00 ANXIETY DISORDER | 1 0.01 4.01 AORTIC BYPASS | 2 0.02 4.03 AORTIC VALVE REPLACEMENT | 1 0.01 4.04 APLASTIC ANAEMIA | 6 0.06 4.10 APPETITE DISORDER | 1 0.01 4.11 ARRHYTHMIA | 4 0.04 4.15 ARTERIAL OCCLUSIVE DISEASE | 2 0.02 4.17 ARTERIOGRAM CORONARY | 1 0.01 4.18 ARTERIOSCLEROSIS CORONARY ARTERY | 1 0.01 4.19 ARTERIOSCLEROSIS OBLITERANS | 3 0.03 4.22 ARTERITIS | 2 0.02 4.24 ARTHRALGIA | 21 0.21 4.45 ARTHRITIS | 21 0.21 4.66 ARTHRITIS BACTERIAL | 2 0.02 4.68 ARTHROGRAM | 1 0.01 4.69 ARTHROPATHY | 1 0.01 4.70 ARTHROPOD BITE | 1 0.01 4.71 ASCITES | 13 0.13 4.84 ASTEATOSIS | 1 0.01 4.85 ASTHENIA | 1 0.01 4.86 ASTHMA | 123 1.23 6.09 ATRIAL FIBRILLATION | 44 0.44 6.53 ATRIAL FLUTTER | 1 0.01 6.54 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 9 0.09 6.63 AUTISM SPECTRUM DISORDER | 1 0.01 6.64 AUTOIMMUNE THROMBOCYTOPENIA | 1 0.01 6.65 AVIAN INFLUENZA | 1 0.01 6.66 B-CELL LYMPHOMA | 6 0.06 6.72 BACK DISORDER | 1 0.01 6.73 BACK INJURY | 1 0.01 6.74 BACK PAIN | 44 0.44 7.18 BACTERAEMIA | 3 0.03 7.21 BACTERIAL INFECTION | 12 0.12 7.33 BACTERIAL SEPSIS | 1 0.01 7.34 BALANCE DISORDER | 1 0.01 7.35 BARRETT'S OESOPHAGUS | 1 0.01 7.36 BASEDOW'S DISEASE | 2 0.02 7.38 BEHCET'S SYNDROME | 5 0.05 7.43 BENIGN PROSTATIC HYPERPLASIA | 11 0.11 7.54 BILE DUCT CANCER | 2 0.02 7.56 BILIARY DYSKINESIA | 2 0.02 7.58 BIPOLAR DISORDER | 50 0.50 8.08 BIPOLAR I DISORDER | 26 0.26 8.34 BLADDER CANCER | 3 0.03 8.37 BLADDER DILATATION | 1 0.01 8.38 BLADDER DISORDER | 3 0.03 8.41 BLADDER SPASM | 1 0.01 8.42 BLEPHARITIS | 1 0.01 8.43 BLINDNESS UNILATERAL | 1 0.01 8.44 BLOOD CALCIUM | 1 0.01 8.45 BLOOD CALCIUM DECREASED | 2 0.02 8.47 BLOOD CHOLESTEROL | 11 0.11 8.58 BLOOD CHOLESTEROL ABNORMAL | 2 0.02 8.60 BLOOD CHOLESTEROL DECREASED | 1 0.01 8.61 BLOOD CHOLESTEROL INCREASED | 56 0.56 9.17 BLOOD GLUCOSE | 1 0.01 9.18 BLOOD GLUCOSE INCREASED | 1 0.01 9.19 BLOOD IRON | 1 0.01 9.20 BLOOD IRON DECREASED | 1 0.01 9.21 BLOOD IRON INCREASED | 1 0.01 9.22 BLOOD MAGNESIUM DECREASED | 1 0.01 9.23 BLOOD PHOSPHORUS DECREASED | 1 0.01 9.24 BLOOD PHOSPHORUS INCREASED | 3 0.03 9.27 BLOOD POTASSIUM DECREASED | 3 0.03 9.30 BLOOD PRESSURE | 19 0.19 9.49 BLOOD PRESSURE INCREASED | 5 0.05 9.54 BLOOD PRESSURE MANAGEMENT | 2 0.02 9.56 BLOOD TRIGLYCERIDES ABNORMAL | 2 0.02 9.58 BLOOD TRIGLYCERIDES INCREASED | 7 0.07 9.65 BLOOD URIC ACID INCREASED | 1 0.01 9.66 BODY HEIGHT BELOW NORMAL | 1 0.01 9.67 BONE DENSITY DECREASED | 4 0.04 9.71 BONE DISORDER | 6 0.06 9.77 BONE LESION | 1 0.01 9.78 BONE MARROW TRANSPLANT | 1 0.01 9.79 BONE MARROW TRANSPLANT REJECTION | 2 0.02 9.81 BONE PAIN | 5 0.05 9.86 BONE SARCOMA | 5 0.05 9.91 BORDERLINE PERSONALITY DISORDER | 2 0.02 9.93 BRAIN NEOPLASM | 1 0.01 9.94 BREAKTHROUGH PAIN | 4 0.04 9.98 BREAST CANCER | 94 0.94 10.92 BREAST CANCER METASTATIC | 10 0.10 11.02 BREAST CANCER STAGE III | 1 0.01 11.03 BRONCHIAL HYPERREACTIVITY | 1 0.01 11.04 BRONCHIECTASIS | 1 0.01 11.05 BRONCHIOLOALVEOLAR CARCINOMA | 2 0.02 11.07 BRONCHITIS | 17 0.17 11.24 BRONCHITIS CHRONIC | 1 0.01 11.25 BRONCHOPULMONARY ASPERGILLOSIS | 2 0.02 11.27 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC | 1 0.01 11.28 BRONCHOPULMONARY DYSPLASIA | 2 0.02 11.30 BRUXISM | 1 0.01 11.31 BURNING SENSATION | 1 0.01 11.32 BURSITIS | 1 0.01 11.33 CANCER PAIN | 17 0.17 11.50 CANDIDIASIS | 6 0.06 11.56 CARCINOID SYNDROME | 3 0.03 11.59 CARCINOID TUMOUR | 7 0.07 11.66 CARDIAC DISORDER | 25 0.25 11.91 CARDIAC FAILURE | 16 0.16 12.07 CARDIAC FAILURE ACUTE | 3 0.03 12.10 CARDIAC FAILURE CONGESTIVE | 3 0.03 12.13 CARDIAC OPERATION | 35 0.35 12.48 CARDIAC PACEMAKER INSERTION | 1 0.01 12.49 CARDIOMYOPATHY | 7 0.07 12.56 CARDIOVASCULAR EVENT PROPHYLAXIS | 7 0.07 12.63 CAREGIVER | 1 0.01 12.64 CAROTID ARTERY BYPASS | 1 0.01 12.65 CAROTID ARTERY STENOSIS | 1 0.01 12.66 CARPAL TUNNEL SYNDROME | 2 0.02 12.68 CASTLEMAN'S DISEASE | 3 0.03 12.71 CATHETER PLACEMENT | 1 0.01 12.72 CATHETERISATION CARDIAC | 9 0.09 12.81 CELLULITIS | 4 0.04 12.85 CENTRAL PAIN SYNDROME | 1 0.01 12.86 CEREBRAL ATROPHY | 2 0.02 12.88 CEREBRAL HAEMORRHAGE | 1 0.01 12.89 CEREBRAL INFARCTION | 2 0.02 12.91 CEREBROVASCULAR ACCIDENT | 9 0.09 13.00 CEREBROVASCULAR DISORDER | 2 0.02 13.02 CERVICOBRACHIAL SYNDROME | 1 0.01 13.03 CHEMOTHERAPY | 5 0.05 13.08 CHEST PAIN | 1 0.01 13.09 CHILLS | 2 0.02 13.11 CHOLANGITIS | 1 0.01 13.12 CHOLANGITIS SCLEROSING | 2 0.02 13.14 CHOROIDAL NEOVASCULARISATION | 1 0.01 13.15 CHRONIC GRAFT VERSUS HOST DISEASE | 4 0.04 13.19 CHRONIC LYMPHOCYTIC LEUKAEMIA | 12 0.12 13.31 CHRONIC MYELOID LEUKAEMIA | 30 0.30 13.61 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 54 0.54 14.15 CHRONIC SINUSITIS | 1 0.01 14.16 CLOSTRIDIAL INFECTION | 1 0.01 14.17 COAGULOPATHY | 1 0.01 14.18 COGNITIVE DISORDER | 2 0.02 14.20 COLITIS | 3 0.03 14.23 COLITIS ULCERATIVE | 28 0.28 14.51 COLON CANCER | 11 0.11 14.62 COLON CANCER METASTATIC | 4 0.04 14.66 COLON CANCER STAGE III | 1 0.01 14.67 COLONOSCOPY | 2 0.02 14.69 COLORECTAL CANCER | 17 0.17 14.86 COMPLEX PARTIAL SEIZURES | 4 0.04 14.90 COMPRESSION FRACTURE | 1 0.01 14.91 COMPUTERISED TOMOGRAM | 1 0.01 14.92 COMPUTERISED TOMOGRAM ABDOMEN | 2 0.02 14.94 CONGENITAL ANAEMIA | 1 0.01 14.95 CONJUNCTIVAL HYPERAEMIA | 1 0.01 14.96 CONJUNCTIVITIS | 1 0.01 14.97 CONJUNCTIVITIS ALLERGIC | 1 0.01 14.98 CONSTIPATION | 37 0.37 15.35 CONSTIPATION PROPHYLAXIS | 2 0.02 15.37 CONTRACEPTION | 49 0.49 15.86 CONVALESCENT | 1 0.01 15.87 CONVULSION | 25 0.25 16.12 CORNEAL EROSION | 1 0.01 16.13 CORONARY ARTERIAL STENT INSERTION | 3 0.03 16.16 CORONARY ARTERY BYPASS | 177 1.77 17.93 CORONARY ARTERY DISEASE | 14 0.14 18.07 COUGH | 18 0.18 18.25 CROHN'S DISEASE | 137 1.37 19.62 CYSTITIS | 5 0.05 19.67 CYTOMEGALOVIRUS INFECTION | 1 0.01 19.68 DEAFNESS | 1 0.01 19.69 DECREASED APPETITE | 3 0.03 19.72 DEEP VEIN THROMBOSIS | 6 0.06 19.78 DEHYDRATION | 3 0.03 19.81 DEMENTIA | 5 0.05 19.86 DEMENTIA ALZHEIMER'S TYPE | 14 0.14 20.00 DEMENTIA WITH LEWY BODIES | 1 0.01 20.01 DEMYELINATING POLYNEUROPATHY | 1 0.01 20.02 DENTAL CARE | 1 0.01 20.03 DENTAL DISORDER PROPHYLAXIS | 1 0.01 20.04 DENTAL OPERATION | 1 0.01 20.05 DEPRESSED MOOD | 4 0.04 20.09 DEPRESSION | 213 2.13 22.22 DEPRESSIVE SYMPTOM | 11 0.11 22.33 DERMATOMYOSITIS | 1 0.01 22.34 DIABETES MELLITUS | 188 1.88 24.22 DIABETIC KETOACIDOSIS | 2 0.02 24.24 DIABETIC NEPHROPATHY | 1 0.01 24.25 DIABETIC NEUROPATHY | 7 0.07 24.32 DIABETIC RELATIVE | 2 0.02 24.34 DIAGNOSTIC PROCEDURE | 4 0.04 24.38 DIALYSIS | 4 0.04 24.42 DIARRHOEA | 12 0.12 24.54 DIFFUSE LARGE B-CELL LYMPHOMA | 28 0.28 24.82 DIHYDROTESTOSTERONE INCREASED | 1 0.01 24.83 DISEASE COMPLICATION | 1 0.01 24.84 DISSEMINATED CYTOMEGALOVIRAL INFECTION | 2 0.02 24.86 DISSEMINATED INTRAVASCULAR COAGULATION | 1 0.01 24.87 DIURETIC THERAPY | 7 0.07 24.94 DIVERTICULITIS | 8 0.08 25.02 DIZZINESS | 7 0.07 25.09 DRESSLER'S SYNDROME | 1 0.01 25.10 DRUG ABUSE | 11 0.11 25.21 DRUG EXPOSURE DURING PREGNANCY | 77 0.77 25.98 DRUG EXPOSURE VIA BREAST MILK | 1 0.01 25.99 DRUG THERAPY | 2 0.02 26.01 DRUG TOXICITY PROPHYLAXIS | 1 0.01 26.02 DRY EYE | 3 0.03 26.05 DRY SKIN | 2 0.02 26.07 DUCHENNE MUSCULAR DYSTROPHY | 1 0.01 26.08 DUODENAL ULCER | 2 0.02 26.10 DUODENAL ULCER PERFORATION | 8 0.08 26.18 DWARFISM | 1 0.01 26.19 DYSLIPIDAEMIA | 5 0.05 26.24 DYSPEPSIA | 11 0.11 26.35 DYSPNOEA | 9 0.09 26.44 DYSURIA | 5 0.05 26.49 EAR INFECTION | 7 0.07 26.56 ECHINOCOCCIASIS | 6 0.06 26.62 ECZEMA | 6 0.06 26.68 ELECTROCARDIOGRAM QT PROLONGED | 1 0.01 26.69 EMPHYSEMA | 7 0.07 26.76 ENCEPHALITIS | 1 0.01 26.77 ENCEPHALITIS HERPES | 3 0.03 26.80 ENDOMETRIAL CANCER | 2 0.02 26.82 ENDOMETRIAL DISORDER | 1 0.01 26.83 ENDOMETRIOSIS | 4 0.04 26.87 ENDOTRACHEAL INTUBATION | 1 0.01 26.88 ENTERITIS INFECTIOUS | 1 0.01 26.89 ENTEROCOLITIS HAEMORRHAGIC | 1 0.01 26.90 ENTEROCOLITIS INFECTIOUS | 1 0.01 26.91 ENTEROCUTANEOUS FISTULA | 1 0.01 26.92 EOSINOPENIA | 1 0.01 26.93 EPIDIDYMITIS | 1 0.01 26.94 EPIDURAL ANAESTHESIA | 2 0.02 26.96 EPILEPSY | 28 0.28 27.24 EPISTAXIS | 1 0.01 27.25 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOP.. | 5 0.05 27.30 ERECTILE DYSFUNCTION | 12 0.12 27.42 ERYSIPELAS | 1 0.01 27.43 ERYTHEMA MULTIFORME | 4 0.04 27.47 ESCHERICHIA URINARY TRACT INFECTION | 2 0.02 27.49 ESSENTIAL HYPERTENSION | 2 0.02 27.51 EVIDENCE BASED TREATMENT | 2 0.02 27.53 EX-TOBACCO USER | 1 0.01 27.54 EXTRANODAL MARGINAL ZONE B-CELL LYMPH.. | 3 0.03 27.57 EYE DISORDER | 1 0.01 27.58 EYE PAIN | 2 0.02 27.60 FABRY'S DISEASE | 5 0.05 27.65 FACIAL PAIN | 1 0.01 27.66 FACTOR V LEIDEN MUTATION | 1 0.01 27.67 FACTOR VIII DEFICIENCY | 1 0.01 27.68 FALLOPIAN TUBE CANCER | 1 0.01 27.69 FATIGUE | 6 0.06 27.75 FEBRILE CONVULSION | 1 0.01 27.76 FEBRILE NEUTROPENIA | 2 0.02 27.78 FEELING COLD | 1 0.01 27.79 FEMUR FRACTURE | 1 0.01 27.80 FIBROMYALGIA | 27 0.27 28.07 FISTULOGRAM | 1 0.01 28.08 FLATULENCE | 3 0.03 28.11 FLUID OVERLOAD | 3 0.03 28.14 FLUID RETENTION | 4 0.04 28.18 FOLATE DEFICIENCY | 2 0.02 28.20 FOOD ALLERGY | 1 0.01 28.21 FOOT OPERATION | 1 0.01 28.22 FUNGAL INFECTION | 5 0.05 28.27 FURUNCLE | 1 0.01 28.28 GASTRIC CANCER | 5 0.05 28.33 GASTRIC DISORDER | 11 0.11 28.44 GASTRIC INFECTION | 1 0.01 28.45 GASTRIC PH DECREASED | 1 0.01 28.46 GASTRIC ULCER | 9 0.09 28.55 GASTRIC ULCER SURGERY | 1 0.01 28.56 GASTRINOMA | 2 0.02 28.58 GASTRITIS | 19 0.19 28.77 GASTRITIS HAEMORRHAGIC | 1 0.01 28.78 GASTRITIS PROPHYLAXIS | 8 0.08 28.86 GASTROENTERITIS | 1 0.01 28.87 GASTROINTESTINAL CARCINOMA | 1 0.01 28.88 GASTROINTESTINAL DISORDER | 1 0.01 28.89 GASTROINTESTINAL HYPOMOTILITY | 2 0.02 28.91 GASTROINTESTINAL MOTILITY DISORDER | 1 0.01 28.92 GASTROINTESTINAL STROMAL TUMOUR | 14 0.14 29.06 GASTROINTESTINAL ULCER | 1 0.01 29.07 GASTROOESOPHAGEAL CANCER | 3 0.03 29.10 GASTROOESOPHAGEAL REFLUX DISEASE | 29 0.29 29.39 GASTROOESOPHAGEAL REFLUX PROPHYLAXIS | 1 0.01 29.40 GENERAL ANAESTHESIA | 6 0.06 29.46 GENERAL PHYSICAL HEALTH DETERIORATION | 2 0.02 29.48 GENERAL SYMPTOM | 1 0.01 29.49 GENERALISED ANXIETY DISORDER | 5 0.05 29.54 GERM CELL CANCER | 13 0.13 29.67 GESTATIONAL DIABETES | 5 0.05 29.72 GLAUCOMA | 18 0.18 29.90 GLIOBLASTOMA | 2 0.02 29.92 GLIOBLASTOMA MULTIFORME | 2 0.02 29.94 GLIOMA | 6 0.06 30.00 GLUCOSE TOLERANCE IMPAIRED | 1 0.01 30.01 GLYCOGEN STORAGE DISEASE TYPE II | 1 0.01 30.02 GOUT | 11 0.11 30.13 GOUTY ARTHRITIS | 1 0.01 30.14 GRAFT VERSUS HOST DISEASE | 2 0.02 30.16 GRAND MAL CONVULSION | 2 0.02 30.18 GUN SHOT WOUND | 2 0.02 30.20 H1N1 INFLUENZA | 2 0.02 30.22 HAEMATOPOIETIC NEOPLASM | 1 0.01 30.23 HAEMATOPOIETIC STEM CELL MOBILISATION | 2 0.02 30.25 HAEMODIALYSIS | 5 0.05 30.30 HAEMODYNAMIC INSTABILITY | 1 0.01 30.31 HAEMOLYTIC URAEMIC SYNDROME | 1 0.01 30.32 HAEMOPHILIA | 5 0.05 30.37 HAEMORRHAGE | 2 0.02 30.39 HAEMORRHOIDS | 2 0.02 30.41 HALLUCINATION | 1 0.01 30.42 HALLUCINATION, AUDITORY | 4 0.04 30.46 HAND-FOOT-AND-MOUTH DISEASE | 2 0.02 30.48 HEAD AND NECK CANCER | 13 0.13 30.61 HEAD INJURY | 1 0.01 30.62 HEADACHE | 11 0.11 30.73 HEART RATE DECREASED | 1 0.01 30.74 HEART RATE INCREASED | 1 0.01 30.75 HEART RATE IRREGULAR | 3 0.03 30.78 HEART TRANSPLANT | 14 0.14 30.92 HEART VALVE REPLACEMENT | 2 0.02 30.94 HELICOBACTER GASTRITIS | 1 0.01 30.95 HEMIPARESIS | 1 0.01 30.96 HEPATIC CIRRHOSIS | 1 0.01 30.97 HEPATIC ECHINOCOCCIASIS | 1 0.01 30.98 HEPATIC FUNCTION ABNORMAL | 7 0.07 31.05 HEPATIC NEOPLASM MALIGNANT | 13 0.13 31.18 HEPATITIS B | 8 0.08 31.26 HEPATITIS C | 37 0.37 31.63 HERPES OPHTHALMIC | 1 0.01 31.64 HERPES SIMPLEX | 1 0.01 31.65 HERPES VIRUS INFECTION | 3 0.03 31.68 HERPES ZOSTER | 19 0.19 31.87 HERPES ZOSTER OTICUS | 1 0.01 31.88 HIATUS HERNIA | 2 0.02 31.90 HICCUPS | 1 0.01 31.91 HIDRADENITIS | 1 0.01 31.92 HIGH DENSITY LIPOPROTEIN DECREASED | 2 0.02 31.94 HIP ARTHROPLASTY | 2 0.02 31.96 HISTIOCYTOSIS HAEMATOPHAGIC | 1 0.01 31.97 HISTOPLASMOSIS | 2 0.02 31.99 HIV INFECTION | 179 1.79 33.78 HIV TEST | 1 0.01 33.79 HIV TEST POSITIVE | 9 0.09 33.88 HODGKIN'S DISEASE | 9 0.09 33.97 HODGKIN'S DISEASE LYMPHOCYTE PREDOMIN.. | 2 0.02 33.99 HORMONE LEVEL ABNORMAL | 1 0.01 34.00 HORMONE REPLACEMENT THERAPY | 33 0.33 34.33 HORMONE THERAPY | 1 0.01 34.34 HOT FLUSH | 2 0.02 34.36 HYDROCEPHALUS | 1 0.01 34.37 HYPERCALCAEMIA | 2 0.02 34.39 HYPERCALCAEMIA OF MALIGNANCY | 2 0.02 34.41 HYPERCHOLESTEROLAEMIA | 29 0.29 34.70 HYPERGLYCAEMIA | 1 0.01 34.71 HYPERKALAEMIA | 2 0.02 34.73 HYPERLIPIDAEMIA | 21 0.21 34.94 HYPERPARATHYROIDISM | 3 0.03 34.97 HYPERPARATHYROIDISM SECONDARY | 4 0.04 35.01 HYPERPHOSPHATAEMIA | 7 0.07 35.08 HYPERPROLACTINAEMIA | 1 0.01 35.09 HYPERSENSITIVITY | 14 0.14 35.23 HYPERTENSION | 415 4.15 39.38 HYPERTHERMIA | 1 0.01 39.39 HYPERTHYROIDISM | 3 0.03 39.42 HYPERTONIC BLADDER | 2 0.02 39.44 HYPERURICAEMIA | 6 0.06 39.50 HYPOAESTHESIA | 2 0.02 39.52 HYPOALBUMINAEMIA | 1 0.01 39.53 HYPOCALCAEMIA | 2 0.02 39.55 HYPOGLYCAEMIA | 2 0.02 39.57 HYPOKALAEMIA | 8 0.08 39.65 HYPOMAGNESAEMIA | 1 0.01 39.66 HYPOMANIA | 1 0.01 39.67 HYPONATRAEMIA | 3 0.03 39.70 HYPOPARATHYROIDISM | 1 0.01 39.71 HYPOPHOSPHATAEMIA | 1 0.01 39.72 HYPOPITUITARISM | 1 0.01 39.73 HYPOPROTEINAEMIA | 1 0.01 39.74 HYPOTENSION | 2 0.02 39.76 HYPOTHYROIDISM | 39 0.39 40.15 HYPOVITAMINOSIS | 2 0.02 40.17 IDIOPATHIC PULMONARY FIBROSIS | 5 0.05 40.22 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 31 0.31 40.53 ILL-DEFINED DISORDER | 1 0.01 40.54 IMAGING PROCEDURE | 17 0.17 40.71 IMMUNE ENHANCEMENT THERAPY | 1 0.01 40.72 IMMUNISATION | 10 0.10 40.82 IMMUNODEFICIENCY COMMON VARIABLE | 1 0.01 40.83 IMMUNOSUPPRESSANT DRUG THERAPY | 4 0.04 40.87 IMMUNOSUPPRESSION | 6 0.06 40.93 IMPAIRED GASTRIC EMPTYING | 1 0.01 40.94 IN VITRO FERTILISATION | 4 0.04 40.98 INCONTINENCE | 2 0.02 41.00 INCREASED APPETITE | 1 0.01 41.01 INDUCTION AND MAINTENANCE OF ANAESTHE.. | 2 0.02 41.03 INDUCTION OF ANAESTHESIA | 1 0.01 41.04 INFANTILE SPASMS | 2 0.02 41.06 INFARCTION | 6 0.06 41.12 INFECTION | 26 0.26 41.38 INFECTION PROPHYLAXIS | 8 0.08 41.46 INFECTIOUS MONONUCLEOSIS | 1 0.01 41.47 INFERTILITY | 2 0.02 41.49 INFLAMMATION | 21 0.21 41.70 INFLAMMATORY BOWEL DISEASE | 10 0.10 41.80 INFLUENZA | 5 0.05 41.85 INFLUENZA IMMUNISATION | 2 0.02 41.87 INFUSION | 1 0.01 41.88 INJECTION | 1 0.01 41.89 INJECTION SITE THROMBOSIS | 1 0.01 41.90 INJURY | 2 0.02 41.92 INSOMNIA | 61 0.61 42.53 INTERSTITIAL LUNG DISEASE | 3 0.03 42.56 INTERVERTEBRAL DISC DEGENERATION | 2 0.02 42.58 INTESTINAL OBSTRUCTION | 1 0.01 42.59 INTRA-AORTIC BALLOON PLACEMENT | 1 0.01 42.60 INTRACRANIAL PRESSURE INCREASED | 1 0.01 42.61 INTRAVENOUS CATHETER MANAGEMENT | 1 0.01 42.62 IRON DEFICIENCY ANAEMIA | 5 0.05 42.67 IRON METABOLISM DISORDER | 2 0.02 42.69 IRON OVERLOAD | 14 0.14 42.83 IRRITABILITY | 1 0.01 42.84 IRRITABLE BOWEL SYNDROME | 1 0.01 42.85 ISCHAEMIC HEART DISEASE PROPHYLAXIS | 1 0.01 42.86 JAUNDICE | 1 0.01 42.87 JOINT STIFFNESS | 1 0.01 42.88 JOINT SWELLING | 2 0.02 42.90 JUVENILE ARTHRITIS | 4 0.04 42.94 LABYRINTHITIS | 1 0.01 42.95 LANGERHANS' CELL HISTIOCYTOSIS | 1 0.01 42.96 LARGE CELL LUNG CANCER STAGE IV | 1 0.01 42.97 LARGE INTESTINE CARCINOMA | 4 0.04 43.01 LAXATIVE SUPPORTIVE CARE | 3 0.03 43.04 LEPROSY | 2 0.02 43.06 LEUKAEMIA | 1 0.01 43.07 LEUKAEMIC LYMPHOMA | 1 0.01 43.08 LICE INFESTATION | 1 0.01 43.09 LIGAMENT INJURY | 1 0.01 43.10 LIGAMENT SPRAIN | 1 0.01 43.11 LIPID METABOLISM DISORDER | 1 0.01 43.12 LIVER ABSCESS | 2 0.02 43.14 LIVER TRANSPLANT | 14 0.14 43.28 LOCAL ANAESTHESIA | 11 0.11 43.39 LOCALISED INFECTION | 1 0.01 43.40 LOW DENSITY LIPOPROTEIN INCREASED | 1 0.01 43.41 LOWER EXTREMITY MASS | 1 0.01 43.42 LOWER RESPIRATORY TRACT INFECTION | 2 0.02 43.44 LUNG ADENOCARCINOMA | 3 0.03 43.47 LUNG ADENOCARCINOMA METASTATIC | 1 0.01 43.48 LUNG ADENOCARCINOMA RECURRENT | 1 0.01 43.49 LUNG ADENOCARCINOMA STAGE III | 2 0.02 43.51 LUNG CANCER METASTATIC | 1 0.01 43.52 LUNG CARCINOMA CELL TYPE UNSPECIFIED .. | 1 0.01 43.53 LUNG DISORDER | 5 0.05 43.58 LUNG INFECTION | 1 0.01 43.59 LUNG INFILTRATION | 1 0.01 43.60 LUNG NEOPLASM MALIGNANT | 6 0.06 43.66 LUPUS-LIKE SYNDROME | 1 0.01 43.67 LYMPH NODE TUBERCULOSIS | 5 0.05 43.72 LYMPHANGIOSIS CARCINOMATOSA | 1 0.01 43.73 LYMPHOCYTIC LEUKAEMIA | 2 0.02 43.75 LYMPHOMA | 5 0.05 43.80 LYMPHOPLASMACYTOID LYMPHOMA/IMMUNOCYT.. | 3 0.03 43.83 MACULAR DEGENERATION | 8 0.08 43.91 MACULAR OEDEMA | 1 0.01 43.92 MAINTENANCE OF ANAESTHESIA | 2 0.02 43.94 MAJOR DEPRESSION | 9 0.09 44.03 MALAISE | 7 0.07 44.10 MALARIA PROPHYLAXIS | 2 0.02 44.12 MANTLE CELL LYMPHOMA | 13 0.13 44.25 MASS | 1 0.01 44.26 MEDICAL DIET | 10 0.10 44.36 MEDULLOBLASTOMA | 24 0.24 44.60 MEMORY IMPAIRMENT | 3 0.03 44.63 MENINGITIS BACTERIAL | 3 0.03 44.66 MENOPAUSAL SYMPTOMS | 2 0.02 44.68 MENOPAUSE | 4 0.04 44.72 MENORRHAGIA | 2 0.02 44.74 MENSTRUAL CYCLE MANAGEMENT | 2 0.02 44.76 MENSTRUATION IRREGULAR | 3 0.03 44.79 MENTAL DISORDER | 2 0.02 44.81 MESOTHELIOMA | 2 0.02 44.83 MESOTHERAPY | 2 0.02 44.85 METABOLIC SYNDROME | 1 0.01 44.86 METASTASES TO BONE | 17 0.17 45.03 METASTASES TO CHEST WALL | 1 0.01 45.04 METASTASES TO SPINE | 1 0.01 45.05 METASTASIS | 2 0.02 45.07 METASTATIC CARCINOID TUMOUR | 1 0.01 45.08 METASTATIC RENAL CELL CARCINOMA | 16 0.16 45.24 MICROALBUMINURIA | 1 0.01 45.25 MIGRAINE | 18 0.18 45.43 MIGRAINE PROPHYLAXIS | 4 0.04 45.47 MINERAL SUPPLEMENTATION | 10 0.10 45.57 MITRAL VALVE STENOSIS | 1 0.01 45.58 MOOD SWINGS | 1 0.01 45.59 MOUTH ULCERATION | 1 0.01 45.60 MUCOPOLYSACCHARIDOSIS II | 5 0.05 45.65 MUCOSAL INFLAMMATION | 1 0.01 45.66 MULTIPLE ALLERGIES | 6 0.06 45.72 MULTIPLE MYELOMA | 116 1.16 46.88 MULTIPLE SCLEROSIS | 637 6.37 53.25 MULTIPLE SCLEROSIS RELAPSE | 3 0.03 53.28 MUSCLE INJURY | 4 0.04 53.32 MUSCLE RELAXANT THERAPY | 9 0.09 53.41 MUSCLE SPASMS | 8 0.08 53.49 MUSCLE SPASTICITY | 9 0.09 53.58 MUSCLE TIGHTNESS | 1 0.01 53.59 MUSCULOSKELETAL PAIN | 10 0.10 53.69 MYALGIA | 4 0.04 53.73 MYASTHENIA GRAVIS | 1 0.01 53.74 MYELODYSPLASTIC SYNDROME | 21 0.21 53.95 MYOCARDIAL INFARCTION | 9 0.09 54.04 MYOCLONIC EPILEPSY | 2 0.02 54.06 NARCOLEPSY | 2 0.02 54.08 NASAL CONGESTION | 3 0.03 54.11 NASAL DISCOMFORT | 2 0.02 54.13 NASAL ULCER | 1 0.01 54.14 NASOPHARYNGITIS | 10 0.10 54.24 NAUSEA | 32 0.32 54.56 NECK PAIN | 4 0.04 54.60 NEOPLASM | 3 0.03 54.63 NEOPLASM MALIGNANT | 4 0.04 54.67 NEPHROGENIC ANAEMIA | 3 0.03 54.70 NEPHROTIC SYNDROME | 1 0.01 54.71 NERVE COMPRESSION | 1 0.01 54.72 NERVE INJURY | 1 0.01 54.73 NERVOUSNESS | 3 0.03 54.76 NEURALGIA | 22 0.22 54.98 NEURITIS | 2 0.02 55.00 NEUROENDOCRINE TUMOUR | 3 0.03 55.03 NEUROPATHY PERIPHERAL | 17 0.17 55.20 NEUTROPENIA | 3 0.03 55.23 NICOTINE DEPENDENCE | 1 0.01 55.24 NIGHT SWEATS | 1 0.01 55.25 NIGHTMARE | 4 0.04 55.29 NOCTURIA | 1 0.01 55.30 NON-HODGKIN'S LYMPHOMA | 6 0.06 55.36 NON-SMALL CELL LUNG CANCER | 94 0.94 56.30 NON-SMALL CELL LUNG CANCER METASTATIC | 2 0.02 56.32 NON-SMALL CELL LUNG CANCER STAGE III | 3 0.03 56.35 NON-SMALL CELL LUNG CANCER STAGE IIIB | 4 0.04 56.39 NON-SMALL CELL LUNG CANCER STAGE IV | 3 0.03 56.42 NUCLEAR MAGNETIC RESONANCE IMAGING | 45 0.45 56.87 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 4 0.04 56.91 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 10 0.10 57.01 NUCLEAR MAGNETIC RESONANCE IMAGING TH.. | 1 0.01 57.02 NUTRITIONAL SUPPORT | 2 0.02 57.04 OBESITY | 5 0.05 57.09 OBSESSIVE-COMPULSIVE DISORDER | 6 0.06 57.15 OBSTRUCTION | 3 0.03 57.18 OCULAR HYPERAEMIA | 1 0.01 57.19 ODYNOPHAGIA | 1 0.01 57.20 OEDEMA | 10 0.10 57.30 OEDEMA DUE TO CARDIAC DISEASE | 1 0.01 57.31 OEDEMA PERIPHERAL | 1 0.01 57.32 OESOPHAGEAL ADENOCARCINOMA | 3 0.03 57.35 OESOPHAGEAL CANDIDIASIS | 1 0.01 57.36 OESOPHAGEAL CARCINOMA | 6 0.06 57.42 OESOPHAGEAL PAIN | 2 0.02 57.44 OESOPHAGEAL SPASM | 1 0.01 57.45 OESOPHAGITIS | 1 0.01 57.46 OESTROGEN REPLACEMENT THERAPY | 2 0.02 57.48 OFF LABEL USE | 5 0.05 57.53 ONCHOCERCIASIS | 2 0.02 57.55 OPEN ANGLE GLAUCOMA | 1 0.01 57.56 OPHTHALMOLOGICAL EXAMINATION | 1 0.01 57.57 OPHTHALMOPLEGIC MIGRAINE | 2 0.02 57.59 ORAL CANDIDIASIS | 2 0.02 57.61 ORAL CONTRACEPTION | 2 0.02 57.63 OROPHARYNGEAL PAIN | 6 0.06 57.69 OSTEITIS | 3 0.03 57.72 OSTEITIS DEFORMANS | 1 0.01 57.73 OSTEOARTHRITIS | 20 0.20 57.93 OSTEOMYELITIS | 4 0.04 57.97 OSTEOPENIA | 13 0.13 58.10 OSTEOPOROSIS | 137 1.37 59.47 OSTEOPOROSIS POSTMENOPAUSAL | 4 0.04 59.51 OSTEOPOROSIS PROPHYLAXIS | 11 0.11 59.62 OSTEOPOROTIC FRACTURE | 1 0.01 59.63 OVARIAN CANCER | 7 0.07 59.70 OVARIAN CANCER RECURRENT | 3 0.03 59.73 OVARIAN CYST | 1 0.01 59.74 OVERDOSE | 10 0.10 59.84 PAIN | 147 1.47 61.31 PAIN IN EXTREMITY | 9 0.09 61.40 PAIN MANAGEMENT | 6 0.06 61.46 PAIN PROPHYLAXIS | 1 0.01 61.47 PALLIATIVE CARE | 3 0.03 61.50 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 2 0.02 61.52 PALPITATIONS | 1 0.01 61.53 PANCREATIC CARCINOMA | 3 0.03 61.56 PANCREATIC CARCINOMA METASTATIC | 3 0.03 61.59 PANCREATIC INSUFFICIENCY | 3 0.03 61.62 PANCREATIC NEUROENDOCRINE TUMOUR | 14 0.14 61.76 PANCREATITIS CHRONIC | 1 0.01 61.77 PANCYTOPENIA | 1 0.01 61.78 PANIC ATTACK | 4 0.04 61.82 PANIC DISORDER | 3 0.03 61.85 PARAESTHESIA | 1 0.01 61.86 PARKINSON'S DISEASE | 7 0.07 61.93 PARKINSONISM | 2 0.02 61.95 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA | 1 0.01 61.96 PARTIAL SEIZURES | 2 0.02 61.98 PATENT DUCTUS ARTERIOSUS | 1 0.01 61.99 PATHOGEN RESISTANCE | 1 0.01 62.00 PEMPHIGOID | 4 0.04 62.04 PEMPHIGUS | 3 0.03 62.07 PEPTIC ULCER | 1 0.01 62.08 PERIODONTITIS | 1 0.01 62.09 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 3 0.03 62.12 PERIPHERAL BLOOD STEM CELL APHERESIS | 3 0.03 62.15 PERITONEAL DIALYSIS | 102 1.02 63.17 PERITONITIS | 4 0.04 63.21 PERSONALITY DISORDER | 10 0.10 63.31 PETIT MAL EPILEPSY | 1 0.01 63.32 PHARYNGITIS | 4 0.04 63.36 PINEALOBLASTOMA | 6 0.06 63.42 PITUITARY TUMOUR BENIGN | 4 0.04 63.46 PLASMACYTOMA | 1 0.01 63.47 PLATELET AGGREGATION INHIBITION | 1 0.01 63.48 PLATELET DISORDER | 2 0.02 63.50 PLEURAL MESOTHELIOMA | 1 0.01 63.51 PLEURODESIS | 1 0.01 63.52 PNEUMONIA | 20 0.20 63.72 PNEUMONIA STAPHYLOCOCCAL | 2 0.02 63.74 PNEUMONITIS | 2 0.02 63.76 PNEUMOTHORAX | 1 0.01 63.77 POLLAKIURIA | 4 0.04 63.81 POLYMYALGIA RHEUMATICA | 1 0.01 63.82 POLYNEUROPATHY | 1 0.01 63.83 POLYPOIDAL CHOROIDAL VASCULOPATHY | 2 0.02 63.85 POLYURIA | 1 0.01 63.86 POOR QUALITY SLEEP | 1 0.01 63.87 POST COITAL CONTRACEPTION | 1 0.01 63.88 POST PROCEDURAL HYPOTHYROIDISM | 1 0.01 63.89 POST-TRAUMATIC STRESS DISORDER | 8 0.08 63.97 POSTOPERATIVE ABSCESS | 1 0.01 63.98 POSTOPERATIVE CARE | 3 0.03 64.01 PRE-ECLAMPSIA | 1 0.01 64.02 PRECOCIOUS PUBERTY | 1 0.01 64.03 PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LE.. | 4 0.04 64.07 PREMEDICATION | 61 0.61 64.68 PREMENSTRUAL SYNDROME | 8 0.08 64.76 PREOPERATIVE CARE | 1 0.01 64.77 PRIMARY IMMUNODEFICIENCY SYNDROME | 1 0.01 64.78 PROCEDURAL HYPOTENSION | 2 0.02 64.80 PROCEDURAL PAIN | 5 0.05 64.85 PROCTALGIA | 1 0.01 64.86 PRODUCT USED FOR UNKNOWN INDICATION | 1,739 17.39 82.25 PROLACTINOMA | 1 0.01 82.26 PROLYMPHOCYTIC LEUKAEMIA | 4 0.04 82.30 PROPHYLAXIS | 182 1.82 84.12 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 12 0.12 84.24 PROPHYLAXIS AGAINST GRAFT VERSUS HOST.. | 2 0.02 84.26 PROPHYLAXIS AGAINST HIV INFECTION | 9 0.09 84.35 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 9 0.09 84.44 PROPHYLAXIS OF NAUSEA AND VOMITING | 14 0.14 84.58 PROPHYLAXIS URINARY TRACT INFECTION | 1 0.01 84.59 PROSTATE CANCER | 39 0.39 84.98 PROSTATE CANCER METASTATIC | 8 0.08 85.06 PROSTATE CANCER STAGE II | 5 0.05 85.11 PROSTATE CANCER STAGE IV | 2 0.02 85.13 PROSTATIC DISORDER | 4 0.04 85.17 PROSTATOMEGALY | 2 0.02 85.19 PRURITUS | 4 0.04 85.23 PSORIASIS | 61 0.61 85.84 PSORIATIC ARTHROPATHY | 13 0.13 85.97 PSYCHIATRIC SYMPTOM | 1 0.01 85.98 PSYCHOTIC DISORDER | 13 0.13 86.11 PTERYGIUM OPERATION | 3 0.03 86.14 PULMONARY ARTERIAL HYPERTENSION | 30 0.30 86.44 PULMONARY EMBOLISM | 4 0.04 86.48 PULMONARY FIBROSIS | 1 0.01 86.49 PULMONARY FUNCTION TEST ABNORMAL | 1 0.01 86.50 PULMONARY HYPERTENSION | 2 0.02 86.52 PULMONARY TUBERCULOSIS | 13 0.13 86.65 PURULENT DISCHARGE | 1 0.01 86.66 PYODERMA GANGRENOSUM | 2 0.02 86.68 PYREXIA | 88 0.88 87.56 RASH | 9 0.09 87.65 RASH GENERALISED | 2 0.02 87.67 RASH PRURITIC | 2 0.02 87.69 RAYNAUD'S PHENOMENON | 2 0.02 87.71 RECTAL CANCER | 8 0.08 87.79 RECTAL FISSURE | 1 0.01 87.80 RECTAL HAEMORRHAGE | 1 0.01 87.81 RECTOSIGMOID CANCER | 6 0.06 87.87 REFLUX OESOPHAGITIS | 6 0.06 87.93 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 12 0.12 88.05 RENAL CANCER | 4 0.04 88.09 RENAL CANCER METASTATIC | 2 0.02 88.11 RENAL CELL CARCINOMA | 37 0.37 88.48 RENAL DISORDER | 9 0.09 88.57 RENAL FAILURE | 8 0.08 88.65 RENAL FAILURE ACUTE | 1 0.01 88.66 RENAL FAILURE CHRONIC | 13 0.13 88.79 RENAL IMPAIRMENT | 3 0.03 88.82 RENAL TRANSPLANT | 47 0.47 89.29 RESORPTION BONE INCREASED | 1 0.01 89.30 RESPIRATORY SYNCYTIAL VIRUS INFECTION | 3 0.03 89.33 RESPIRATORY TRACT CONGESTION | 1 0.01 89.34 RESPIRATORY TRACT INFECTION | 6 0.06 89.40 RESTLESS LEGS SYNDROME | 2 0.02 89.42 RESTLESSNESS | 1 0.01 89.43 RHEUMATOID ARTHRITIS | 327 3.27 92.70 RHINITIS | 1 0.01 92.71 RHINITIS ALLERGIC | 4 0.04 92.75 ROSACEA | 1 0.01 92.76 ROUTINE HEALTH MAINTENANCE | 4 0.04 92.80 SALIVARY GLAND CANCER | 1 0.01 92.81 SALIVARY HYPERSECRETION | 2 0.02 92.83 SARCOIDOSIS | 2 0.02 92.85 SARCOMA | 2 0.02 92.87 SCAN | 1 0.01 92.88 SCAN BRAIN | 1 0.01 92.89 SCHIZOAFFECTIVE DISORDER | 9 0.09 92.98 SCHIZOPHRENIA | 71 0.71 93.69 SCHIZOPHRENIA, PARANOID TYPE | 13 0.13 93.82 SCIATICA | 15 0.15 93.97 SCRATCH | 1 0.01 93.98 SEASONAL AFFECTIVE DISORDER | 1 0.01 93.99 SEASONAL ALLERGY | 2 0.02 94.01 SEDATION | 5 0.05 94.06 SEDATIVE THERAPY | 1 0.01 94.07 SELF INJURIOUS BEHAVIOUR | 2 0.02 94.09 SENILE GENITAL ATROPHY | 1 0.01 94.10 SENILE PSYCHOSIS | 1 0.01 94.11 SEPSIS | 1 0.01 94.12 SEPTIC SHOCK | 1 0.01 94.13 SERONEGATIVE ARTHRITIS | 2 0.02 94.15 SERUM FERRITIN INCREASED | 3 0.03 94.18 SERUM SICKNESS | 2 0.02 94.20 SICKLE CELL ANAEMIA | 2 0.02 94.22 SIDEROBLASTIC ANAEMIA | 1 0.01 94.23 SINUS CONGESTION | 1 0.01 94.24 SINUSITIS | 16 0.16 94.40 SJOGREN'S SYNDROME | 2 0.02 94.42 SKIN INFECTION | 1 0.01 94.43 SKIN LESION | 1 0.01 94.44 SKIN PAPILLOMA | 1 0.01 94.45 SKIN ULCER | 1 0.01 94.46 SKIN WRINKLING | 1 0.01 94.47 SLEEP DISORDER | 38 0.38 94.85 SLEEP DISORDER THERAPY | 6 0.06 94.91 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 9 0.09 95.00 SMOKING CESSATION THERAPY | 54 0.54 95.54 SOCIAL PHOBIA | 1 0.01 95.55 SOMATISATION DISORDER | 3 0.03 95.58 SOMNOLENCE | 2 0.02 95.60 SPINAL FRACTURE | 1 0.01 95.61 SPINAL FUSION SURGERY | 1 0.01 95.62 SPINAL OSTEOARTHRITIS | 5 0.05 95.67 SQUAMOUS CELL CARCINOMA | 2 0.02 95.69 STAPHYLOCOCCAL INFECTION | 2 0.02 95.71 STATUS EPILEPTICUS | 1 0.01 95.72 STEM CELL TRANSPLANT | 5 0.05 95.77 STENT PLACEMENT | 3 0.03 95.80 STEROID THERAPY | 2 0.02 95.82 STREPTOCOCCAL INFECTION | 2 0.02 95.84 SUICIDAL IDEATION | 1 0.01 95.85 SUPPLEMENTATION THERAPY | 13 0.13 95.98 SUPPRESSED LACTATION | 1 0.01 95.99 SUPRAVENTRICULAR EXTRASYSTOLES | 1 0.01 96.00 SUPRAVENTRICULAR TACHYCARDIA | 1 0.01 96.01 SURGERY | 4 0.04 96.05 SWELLING | 2 0.02 96.07 SYNOVITIS | 2 0.02 96.09 SYRINGOMYELIA | 1 0.01 96.10 SYSTEMIC LUPUS ERYTHEMATOSUS | 9 0.09 96.19 T-CELL PROLYMPHOCYTIC LEUKAEMIA | 14 0.14 96.33 TACHYCARDIA | 2 0.02 96.35 TARDIVE DYSKINESIA | 3 0.03 96.38 TEETHING | 19 0.19 96.57 TEMPORAL ARTERITIS | 1 0.01 96.58 TENDONITIS | 2 0.02 96.60 TENOSYNOVITIS | 1 0.01 96.61 TENSION | 1 0.01 96.62 THERAPEUTIC EMBOLISATION | 1 0.01 96.63 THINKING ABNORMAL | 1 0.01 96.64 THROMBECTOMY | 2 0.02 96.66 THROMBOCYTOPENIA | 5 0.05 96.71 THROMBOCYTOSIS | 1 0.01 96.72 THROMBOPHLEBITIS | 1 0.01 96.73 THROMBOSIS | 6 0.06 96.79 THROMBOSIS PROPHYLAXIS | 30 0.30 97.09 THYROID CANCER | 1 0.01 97.10 THYROID DISORDER | 9 0.09 97.19 THYROID OPERATION | 1 0.01 97.20 THYROIDECTOMY | 2 0.02 97.22 TINEA PEDIS | 1 0.01 97.23 TOBACCO ABUSE | 1 0.01 97.24 TOBACCO USER | 5 0.05 97.29 TONSILLITIS | 3 0.03 97.32 TONSILLITIS BACTERIAL | 1 0.01 97.33 TOOTH EXTRACTION | 3 0.03 97.36 TOOTHACHE | 4 0.04 97.40 TOXIC EPIDERMAL NECROLYSIS | 1 0.01 97.41 TRANSIENT ISCHAEMIC ATTACK | 1 0.01 97.42 TRAUMATIC HAEMORRHAGE | 1 0.01 97.43 TREMOR | 2 0.02 97.45 TUBERCULIN TEST | 2 0.02 97.47 TUBERCULOSIS | 5 0.05 97.52 TUMOUR HAEMORRHAGE | 1 0.01 97.53 TUMOUR LYSIS SYNDROME | 2 0.02 97.55 TYPE 1 DIABETES MELLITUS | 24 0.24 97.79 TYPE 2 DIABETES MELLITUS | 106 1.06 98.85 ULCER | 4 0.04 98.89 UPPER RESPIRATORY TRACT INFECTION | 6 0.06 98.95 URINARY INCONTINENCE | 2 0.02 98.97 URINARY RETENTION | 2 0.02 98.99 URINARY TRACT DISORDER | 5 0.05 99.04 URINARY TRACT INFECTION | 14 0.14 99.18 URTICARIA | 4 0.04 99.22 UTERINE ATONY | 1 0.01 99.23 UTERINE CANCER | 1 0.01 99.24 UTERINE LEIOMYOMA | 2 0.02 99.26 UVEITIS | 2 0.02 99.28 VAGINAL HAEMORRHAGE | 1 0.01 99.29 VARICELLA | 1 0.01 99.30 VARICES OESOPHAGEAL | 1 0.01 99.31 VASOPRESSIVE THERAPY | 1 0.01 99.32 VENTRICULAR EXTRASYSTOLES | 1 0.01 99.33 VENTRICULAR TACHYCARDIA | 1 0.01 99.34 VIRAL INFECTION | 2 0.02 99.36 VITAMIN B COMPLEX DEFICIENCY | 1 0.01 99.37 VITAMIN D DEFICIENCY | 2 0.02 99.39 VITAMIN SUPPLEMENTATION | 17 0.17 99.56 VITILIGO | 2 0.02 99.58 VOMITING | 4 0.04 99.62 WAGNER'S DISEASE | 1 0.01 99.63 WEGENER'S GRANULOMATOSIS | 7 0.07 99.70 WEIGHT CONTROL | 2 0.02 99.72 WEIGHT DECREASED | 15 0.15 99.87 WEIGHT LOSS DIET | 4 0.04 99.91 WHEEZING | 2 0.02 99.93 WHITE BLOOD CELL COUNT DECREASED | 2 0.02 99.95 WOUND INFECTION | 2 0.02 99.97 WRIST FRACTURE | 1 0.01 99.98 WRONG DRUG ADMINISTERED | 2 0.02 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015